Literature DB >> 12297767

Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.

Manabu Muto1, Shuichi Hironaka, Mari Nakane, Narikazu Boku, Atsushi Ohtsu, Shigeaki Yoshida.   

Abstract

BACKGROUND: Patients with squamous cell carcinoma of the head and neck have a high prevalence of second primary esophageal squamous cell carcinomas. This study assessed the risk of developing second primary esophageal squamous cell carcinomas in patients with squamous cell carcinoma of the head and neck based on multiplicity of Lugol-voiding lesions observed by chromoendoscopy and patient characteristics.
METHODS: Three hundred eighty-nine patients with newly diagnosed squamous cell carcinoma of the head and neck were divided into 4 groups: no Lugol-voiding lesions; several (</=10) small Lugol-voiding lesions; many (>10) small Lugol-voiding lesions; and many irregularly shaped, multiform Lugol-voiding lesions. Relative risk for the development of synchronous second primary esophageal squamous cell carcinomas was investigated by using univariate and multivariate analysis. Metachronous second primary esophageal squamous cell carcinomas was also studied among 227 patients followed more than 1 year after initial examination.
RESULTS: Fifty-four (14%) of the 389 patients were found to have synchronous second primary esophageal squamous cell carcinomas. In particular, 55% of the patients with many irregular-shaped multiform Lugol-voiding lesions had synchronous second primary esophageal squamous cell carcinomas. Univariate analysis showed that the presence of many irregular-shaped multiform Lugol-voiding lesions, drinking habit, male gender, and smoking were significant risk factors for the development of synchronous second primary esophageal squamous cell carcinomas. Multivariate analysis also revealed that many irregular-shaped multiform Lugol-voiding lesions (odds ratio: 21.4; p < 0.001) and drinking habit (odds ratio: 3.3; p < 0.02) were independent risk factors. During follow-up, 7 patients (3%) had metachronous second primary esophageal squamous cell carcinomas; 6 had many irregular-shaped multiform Lugol-voiding lesions and the seventh had many small Lugol-voiding lesions in the background mucosa.
CONCLUSIONS: The presence of numerous irregular-shaped multiform Lugol-voiding lesions was closely associated with second primary esophageal squamous cell carcinomas in patients with squamous cell carcinoma of the head and neck. This might be explained by the concept of "field cancerization." Ingestion of alcohol may play an important role in the occurrence of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297767     DOI: 10.1067/mge.2002.128104

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  44 in total

1.  Esophageal squamous cell carcinoma - precursor lesions and early diagnosis.

Authors:  Antonio Barros Lopes; Renato Borges Fagundes
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

2.  Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial.

Authors:  Manabu Muto; Keiko Minashi; Tomonori Yano; Yutaka Saito; Ichiro Oda; Satoru Nonaka; Tai Omori; Hitoshi Sugiura; Kenichi Goda; Mitsuru Kaise; Haruhiro Inoue; Hideki Ishikawa; Atsushi Ochiai; Tadakazu Shimoda; Hidenobu Watanabe; Hisao Tajiri; Daizo Saito
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

3.  Image-enhanced endoscopy in practice.

Authors:  Sarah McGill; Roy Soetikno; Tonya Kaltenbach
Journal:  Can J Gastroenterol       Date:  2009-11       Impact factor: 3.522

4.  Detection of superficial esophageal squamous cell neoplasia by chromoendoscopy-guided confocal laser endomicroscopy.

Authors:  Jin Huang; Yun-Sheng Yang; Zhong-Sheng Lu; Shuang-Fang Wang; Jing Yang; Jing Yuan
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

5.  Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening.

Authors:  Yasushi Yamasaki; Ryuta Takenaka; Keisuke Hori; Koji Takemoto; Seiji Kawano; Yoshiro Kawahara; Hiroyuki Okada; Shigeatsu Fujiki; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

6.  Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.

Authors:  Chikatoshi Katada; Tetsuji Yokoyama; Tomonori Yano; Ichiro Oda; Yuichi Shimizu; Hisashi Doyama; Tomoyuki Koike; Kohei Takizawa; Motohiro Hirao; Hiroyuki Okada; Takako Yoshii; Yutaro Kubota; Takenori Yamanouchi; Takashi Tsuda; Tai Omori; Nozomu Kobayashi; Haruhisa Suzuki; Satoshi Tanabe; Keisuke Hori; Norisuke Nakayama; Hirofumi Kawakubo; Naomi Kakushima; Yasumasa Matsuo; Hideki Ishikawa; Akira Yokoyama; Manabu Muto
Journal:  Esophagus       Date:  2019-07-08       Impact factor: 4.230

Review 7.  Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature.

Authors:  C Piazza; O Dessouky; G Peretti; D Cocco; L De Benedetto; P Nicolai
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-04       Impact factor: 2.124

8.  Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.

Authors:  D Boller; P Spieler; R Schoenegg; J Neuweiler; D Kradolfer; R Studer; R Grossenbacher; U Zuercher; C Meyenberger; J Borovicka
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

9.  Gastric mucosal changes caused by Lugol's iodine solution spray: endoscopic features of 64 cases on screening esophagogastroduodenoscopy.

Authors:  Daisuke Tsurumaru; Takashi Utsunomiya; Shuji Matsuura; Masahiro Komori; Satoshi Kawanami; Tatsuyuki Ishibashi; Hiroshi Honda
Journal:  Gastroenterol Res Pract       Date:  2010-04-12       Impact factor: 2.260

Review 10.  [Coincidental squamous cell cancers of the esophagus, head, and neck: risk and screening].

Authors:  H Scherübl; J Steinberg; C Schwertner; P Mir-Salim; U Stölzel; E-M de Villiers
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.